277 related articles for article (PubMed ID: 29484995)
1. Biodegradable Microspheres as Intravitreal Delivery Systems for Prolonged Drug Release. What is their Eminence in the Nanoparticle Era?
Gavini E; Bonferoni MC; Rassu G; Obinu A; Ferrari F; Giunchedi P
Curr Drug Deliv; 2018; 15(7):930-940. PubMed ID: 29484995
[TBL] [Abstract][Full Text] [Related]
2. The potential of using biodegradable microspheres in retinal diseases and other intraocular pathologies.
Herrero-Vanrell R; Bravo-Osuna I; Andrés-Guerrero V; Vicario-de-la-Torre M; Molina-Martínez IT
Prog Retin Eye Res; 2014 Sep; 42():27-43. PubMed ID: 24819336
[TBL] [Abstract][Full Text] [Related]
3. Nanocarrier mediated retinal drug delivery: overcoming ocular barriers to treat posterior eye diseases.
Bisht R; Mandal A; Jaiswal JK; Rupenthal ID
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2018 Mar; 10(2):. PubMed ID: 28425224
[TBL] [Abstract][Full Text] [Related]
4. A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases.
Choonara YE; Pillay V; Danckwerts MP; Carmichael TR; du Toit LC
J Pharm Sci; 2010 May; 99(5):2219-39. PubMed ID: 19894268
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticle-loaded biodegradable light-responsive in situ forming injectable implants for effective peptide delivery to the posterior segment of the eye.
Bisht R; Jaiswal JK; Rupenthal ID
Med Hypotheses; 2017 Jun; 103():5-9. PubMed ID: 28571808
[TBL] [Abstract][Full Text] [Related]
6. [Intravitreal drug delivery by microspheres of biodegradable polymers].
Moritera T; Ogura Y; Honda Y; Wada R; Hyon SH; Ikada Y
Nippon Ganka Gakkai Zasshi; 1990 May; 94(5):508-13. PubMed ID: 2220493
[TBL] [Abstract][Full Text] [Related]
7. Drug delivery to the posterior segment of the eye.
Fischer N; Narayanan R; Loewenstein A; Kuppermann BD
Eur J Ophthalmol; 2011; 21 Suppl 6():S20-6. PubMed ID: 23264325
[TBL] [Abstract][Full Text] [Related]
8. Microspheres of biodegradable polymers as a drug-delivery system in the vitreous.
Moritera T; Ogura Y; Honda Y; Wada R; Hyon SH; Ikada Y
Invest Ophthalmol Vis Sci; 1991 May; 32(6):1785-90. PubMed ID: 2032801
[TBL] [Abstract][Full Text] [Related]
9. Biodegradable microspheres for vitreoretinal drug delivery.
Herrero-Vanrell R; Refojo MF
Adv Drug Deliv Rev; 2001 Oct; 52(1):5-16. PubMed ID: 11672871
[TBL] [Abstract][Full Text] [Related]
10. Optimising the controlled release of dexamethasone from a new generation of PLGA-based microspheres intended for intravitreal administration.
Rodríguez Villanueva J; Bravo-Osuna I; Herrero-Vanrell R; Molina Martínez IT; Guzmán Navarro M
Eur J Pharm Sci; 2016 Sep; 92():287-97. PubMed ID: 26987610
[TBL] [Abstract][Full Text] [Related]
11. Light-responsive in situ forming injectable implants for effective drug delivery to the posterior segment of the eye.
Bisht R; Jaiswal JK; Chen YS; Jin J; Rupenthal ID
Expert Opin Drug Deliv; 2016 Jul; 13(7):953-62. PubMed ID: 26967153
[TBL] [Abstract][Full Text] [Related]
12. Poly(ortho ester) nanoparticles targeted for chronic intraocular diseases: ocular safety and localization after intravitreal injection.
Li H; Palamoor M; Jablonski MM
Nanotoxicology; 2016 Oct; 10(8):1152-9. PubMed ID: 27108911
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal hydrogels for sustained release of therapeutic proteins.
Ilochonwu BC; Urtti A; Hennink WE; Vermonden T
J Control Release; 2020 Oct; 326():419-441. PubMed ID: 32717302
[TBL] [Abstract][Full Text] [Related]
14. Drug delivery to the posterior segment of the eye for pharmacologic therapy.
Shah SS; Denham LV; Elison JR; Bhattacharjee PS; Clement C; Huq T; Hill JM
Expert Rev Ophthalmol; 2010 Feb; 5(1):75-93. PubMed ID: 20305803
[TBL] [Abstract][Full Text] [Related]
15. Polymeric, injectable, intravitreal hydrogel devices for posterior segment applications and interventions.
Anwary M; Kumar P; du Toit LC; Choonara YE; Pillay V
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):1074-1081. PubMed ID: 29916734
[TBL] [Abstract][Full Text] [Related]
16. An injectable thermosensitive polymeric hydrogel for sustained release of Avastin® to treat posterior segment disease.
Xie B; Jin L; Luo Z; Yu J; Shi S; Zhang Z; Shen M; Chen H; Li X; Song Z
Int J Pharm; 2015 Jul; 490(1-2):375-83. PubMed ID: 26027491
[TBL] [Abstract][Full Text] [Related]
17. Poly (D,L-lactide-co-glycolide) microspheres for long-term intravitreal delivery of aciclovir: influence of fatty and non-fatty additives.
Martínez-Sancho C; Herrero-Vanrell R; Negro S
J Microencapsul; 2003; 20(6):799-810. PubMed ID: 14594668
[TBL] [Abstract][Full Text] [Related]
18. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis.
Duvvuri S; Janoria KG; Pal D; Mitra AK
J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010
[TBL] [Abstract][Full Text] [Related]
19. The movement of self-assembled amphiphilic polymeric nanoparticles in the vitreous and retina after intravitreal injection.
Koo H; Moon H; Han H; Na JH; Huh MS; Park JH; Woo SJ; Park KH; Kwon IC; Kim K; Kim H
Biomaterials; 2012 Apr; 33(12):3485-93. PubMed ID: 22322197
[TBL] [Abstract][Full Text] [Related]
20. Engineered microparticles based on drug-polymer coprecipitates for ocular-controlled delivery of Ciprofloxacin: influence of technological parameters.
Gavini E; Bonferoni MC; Rassu G; Sandri G; Rossi S; Salis A; Porcu EP; Giunchedi P
Drug Dev Ind Pharm; 2016; 42(4):554-62. PubMed ID: 26482534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
